HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.

Abstract
In recent years the management of human immunodeficiency virus (HIV)-positive individuals has been based on highly active antiretroviral therapy (HAART) comprising a combination of nucleoside analogues or the combination of these agents with protease inhibitors. The aim of the present study was to describe the prevalence of oral lesions in a cohort of 103 HIV-seropositive patients on HAART, to compare these data with the prevalence of lesions prior to HAART and to correlate these finding with the immunologic data. A total of 103 HIV-seropositive patients on HAART were selected. Oral lesions associated with HIV infection and immunological parameters were registered. On re-examination 6 months after the first evaluation, 61/103 patients were available. Comparing the prevalence of oral lesions before and after the onset of HAART, the number of oral lesions was significantly lower (P=0.001). The number of CD4+ cells increased and the viral load decreased significantly after initiation of HAART (P=0.001 and P= 0.0001). On re-examination 6 months later, the prevalence of lesions again decreased significantly (P=0.001). The immunological benefits of HAART may prevent HIV-associated oral lesions in patients with advanced HIV disease. Our results showed that oral manifestations decrease on HAART, but in four patients the immunological effects of therapy did not provide sufficient protection against human papillomavirus (HPV)induced lesions.
AuthorsA M Schmidt-Westhausen, F Priepke, F J Bergmann, P A Reichart
JournalJournal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (J Oral Pathol Med) Vol. 29 Issue 7 Pg. 336-41 (Aug 2000) ISSN: 0904-2512 [Print] Denmark
PMID10947250 (Publication Type: Journal Article)
Chemical References
  • Anti-HIV Agents
  • Drug Combinations
Topics
  • AIDS-Related Opportunistic Infections (epidemiology, prevention & control)
  • Adult
  • Aged
  • Anti-HIV Agents (therapeutic use)
  • Berlin (epidemiology)
  • CD4 Lymphocyte Count
  • Drug Combinations
  • Female
  • HIV Infections (drug therapy, immunology)
  • Humans
  • Male
  • Matched-Pair Analysis
  • Middle Aged
  • Mouth Diseases (epidemiology, etiology, prevention & control)
  • Prevalence
  • Prospective Studies
  • Retrospective Studies
  • Statistics, Nonparametric
  • Viral Load

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: